These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567 [TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cell Responses during Human γ-Herpesvirus Infections. Münz C Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34203904 [TBL] [Abstract][Full Text] [Related]
7. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus. Böni M; Rieble L; Münz C Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502 [TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells. Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735 [TBL] [Abstract][Full Text] [Related]
10. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ. Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151 [TBL] [Abstract][Full Text] [Related]
11. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Müller-Durovic B; Grählert J; Devine OP; Akbar AN; Hess C Aging (Albany NY); 2019 Jan; 11(2):724-740. PubMed ID: 30686790 [TBL] [Abstract][Full Text] [Related]
12. [EBV/KSHV co-infection: an effective partnership]. Gruffat H; Manet E Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100 [TBL] [Abstract][Full Text] [Related]
13. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections. Münz C Front Immunol; 2020; 11():581419. PubMed ID: 33013936 [TBL] [Abstract][Full Text] [Related]
14. KSHV infection of B cells primes protective T cell responses in humanized mice. Caduff N; Rieble L; Böni M; McHugh D; Roshan R; Miley W; Labo N; Barman S; Trivett M; Bosma DMT; Rühl J; Goebels N; Whitby D; Münz C Nat Commun; 2024 Jun; 15(1):4841. PubMed ID: 38844783 [TBL] [Abstract][Full Text] [Related]
16. Reduced frequency of cytotoxic CD56 Pánisová E; Lünemann A; Bürgler S; Kotur M; Lazarovici J; Danu A; Kaulfuss M; Mietz J; Chijioke O; Münz C; Busson P; Berger C; Ghez D; Azzi T Cancer Immunol Immunother; 2022 Jan; 71(1):13-24. PubMed ID: 33993319 [TBL] [Abstract][Full Text] [Related]
17. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation. M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149 [TBL] [Abstract][Full Text] [Related]
18. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma. Jiang Y; Xu D; Zhao Y; Zhang L PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay. Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]